These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36042103)

  • 1. Combined Prophylactic Hyperthermic Intraperitoneal Chemotherapy and Intraoperative Radiotherapy for Localized Gastroesophageal Junction and Gastric Cancer: A Comparative Nonrandomized Study.
    Bazarbashi S; Badran A; Gad AM; Aljubran A; Alzahrani A; Alshibani A; Alrakaf R; Elhassan T; Alsuhaibani A; Elshenawy MA
    Ann Surg Oncol; 2023 Jan; 30(1):426-432. PubMed ID: 36042103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of neoadjuvant chemotherapy combined with prophylactic intraperitoneal hyperthermic chemotherapy for patients diagnosed with clinical T4 gastric cancer who underwent laparoscopic radical gastrectomy: a retrospective cohort study based on propensity score matching.
    Lv CB; Tong LY; Zeng WM; Chen QX; Fang SY; Sun YQ; Cai LS
    World J Surg Oncol; 2024 Sep; 22(1):244. PubMed ID: 39256787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery for gastric carcinoma at high risk of peritoneal carcinomatosis: short and long-term outcomes (GOETH STUDY)-a collaborative randomized controlled trial by ACOI, FONDAZIONE AIOM, SIC, SICE, and SICO.
    Di Giorgio A; Gerardi C; Abatini C; Melotti G; Bonavina L; Torri V; Santullo F; Garattini S; De Luca M; Rulli E; Rulli E; Pacelli F;
    Trials; 2022 Dec; 23(1):969. PubMed ID: 36457115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic hyperthermic intraperitoneal chemotherapy for patients with clinical T4 gastric cancer.
    Lee TY; Hsu CH; Fan HL; Liao GS; Chen TW; Chan DC
    Eur J Surg Oncol; 2022 Sep; 48(9):1972-1979. PubMed ID: 35508455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Safety evaluation of hyperthermic intraperitoneal chemotherapy in patients with local advanced gastric cancer after radical resection for prevention of peritoneal metastasis].
    Lin Y; Shen C; Guo XK; Li Y; Wang DD; Chen X; Wang Z; Wu K; Tao KX; Wu CQ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jan; 25(1):48-55. PubMed ID: 35067034
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II trial of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery.
    Fan B; Bu Z; Zhang J; Zong X; Ji X; Fu T; Jia Z; Zhang Y; Wu X
    BMC Cancer; 2021 Mar; 21(1):216. PubMed ID: 33653317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
    Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperthermic intraperitoneal chemotherapy (HIPEC) plus systemic chemotherapy versus systemic chemotherapy alone in locally advanced gastric cancer after D2 radical resection: a randomized-controlled study.
    Yu P; Huang X; Huang L; Dai G; Xu Q; Fang J; Ye Z; Chai T; Du Y
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11491-11498. PubMed ID: 37392201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic hyperthermic intraperitoneal chemotherapy may benefit the long-term survival of patients after radical gastric cancer surgery.
    Zhuang X; He Y; Ma W
    Sci Rep; 2022 Feb; 12(1):2583. PubMed ID: 35173230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival advantage of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer: experience from a Western tertiary referral center.
    Rosa F; Galiandro F; Ricci R; Di Miceli D; Longo F; Quero G; Tortorelli AP; Alfieri S
    Langenbecks Arch Surg; 2021 Jun; 406(4):1071-1080. PubMed ID: 33611693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study.
    Yu P; Ye Z; Dai G; Zhang Y; Huang L; Du Y; Cheng X
    BMC Cancer; 2020 Nov; 20(1):1108. PubMed ID: 33198674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: A single-center retrospective analysis of 125 patients.
    Ji ZH; Yu Y; Liu G; Zhang YB; An SL; Li B; Li XB; Yan GJ; Li Y
    Eur J Surg Oncol; 2021 Jun; 47(6):1411-1419. PubMed ID: 33293213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival advantage of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer: experience from a Western tertiary referral center.
    Rosa F; Galiandro F; Ricci R; Di Miceli D; Longo F; Quero G; Tortorelli AP; Alfieri S
    Langenbecks Arch Surg; 2021 Sep; 406(6):1847-1857. PubMed ID: 33704561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative hyperthermic intraperitoneal chemotherapy as adjuvant chemotherapy for advanced gastric cancer patients with serosal invasion.
    Kang LY; Mok KT; Liu SI; Tsai CC; Wang BW; Chen IS; Chen YC; Chang BM; Chou NH
    J Chin Med Assoc; 2013 Aug; 76(8):425-31. PubMed ID: 23796652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does hipec improve outcomes in gastric cancer patients treated with perioperative chemotherapy and radical surgery? A propensity-score matched analysis.
    Diniz TP; da Costa WL; Fonseca de Jesus VH; Ribeiro HSC; Diniz AL; de Godoy AL; de Farias IC; Torres SM; Felismino TC; Coimbra FJF
    J Surg Oncol; 2020 Apr; 121(5):823-832. PubMed ID: 31950511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary results of prophylactic HIPEC in patients with locally advanced gastric cancer.
    Graziosi L; Cantarella F; Mingrone E; Gunnellini M; Cavazzoni E; Liberati M; Donini A
    Ann Ital Chir; 2013; 84(5):551-6. PubMed ID: 24140896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The safety and efficacy of prophylactic hyperthermic intraperitoneal chemotherapy for elderly patients with locally advanced gastric cancer: a propensity score matching analysis].
    Yu T; Ma FH; An Q; Cao XL; Xiao G; Wu GJ
    Zhonghua Yi Xue Za Zhi; 2023 Sep; 103(36):2867-2873. PubMed ID: 37726993
    [No Abstract]   [Full Text] [Related]  

  • 18. [Safety of patients undergoing radical resection combined with paclitaxel-based hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer].
    Mei JX; Zhao LY; Zhang WH; Liu K; Chen XL; Yang K; Hu JK
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 May; 27(5):471-477. PubMed ID: 38778687
    [No Abstract]   [Full Text] [Related]  

  • 19. Lobaplatin-based prophylactic hyperthermic intraperitoneal chemotherapy for T4 gastric cancer patients: A retrospective clinical study.
    Zhong Y; Kang W; Hu H; Li W; Zhang J; Tian Y
    Front Oncol; 2023; 13():995618. PubMed ID: 36741012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in gastric cancer patients: A meta-analysis of randomized controlled trials.
    Granieri S; Bonomi A; Frassini S; Chierici AP; Bruno F; Paleino S; Kusamura S; Germini A; Facciorusso A; Deraco M; Cotsoglou C
    Eur J Surg Oncol; 2021 Nov; 47(11):2757-2767. PubMed ID: 34001385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.